Jump to page content

As one measure of the National Strategy for Gene- and Cell-based Therapies (National Strategy GCT) the BIH Biomedical Innovation Academy (BIA) has designed and implemented a new personal funding line called the “national Translational Tandem Program for Gene- and Cell-based Therapies” (nTTP-GCT). 

Objectives and Focus of the nTTP-GCT

Eligibility Criteria

Application and Selection Process

Calls for Proposals


News

More Information

                               You can find more news HERE 

 

          


Early career support with impact: Two nTTP-GCT fellows demonstrate how translation can succeed

Successful publications and follow-up funding are considered key steps in a scientific career. Two fellows of the national Translational Tandem Program for Gene- and Cell-based Therapies (nTTP-GCT) have achieved exactly that within their first year of funding:

Early career support with impact: Two nTTP-GCT Fellows demonstrate how translation can succeed

Dr. rer. nat. Shady Sayed from the Faculty of Medicine Carl Gustav Carus Dresden talks about his successes and future career plans. Find out what research questions drive the Translational Scientist, what decisions have shaped him, and what role the nTTP-GCT personal funding program has played in this.

More Information

Translational Scientist Dr. rer. nat. Lucie Loyal, who conducts research at the BIH in Berlin, presents her research and scientific goals for her recently awarded grant by the Else Kröner-Fresenius-Stiftung (EKFS), which builds on her nTTP-GCT project.
 

More Information

Introduction of the Fellows and the Expert Panel


Program Heads and Program Coordinator

Dr. Nathalie Huber

  • nTTP-GCT Program Head
  • Head of BIH Biomedical Innovation Academy (BIA)
  • Head of Clinician Scientist Office

Dr. Nathalie Huber is joint head of BIA and Head of the Clinician Scientist Office. She holds a PhD in Sociology of Science and has many years of experience in professional science management. Since 2016, she has been contributing her expertise to the empirically based conceptualisation of target group-specific instruments for academic personnel development in biomedicine. Moreover, together with her interdisciplinary team she evaluates career programs and analyses career trajectories in translational research. 

 

Dr. Iwan Christiaan Meij

  • nTTP-GCT Program Head
  • Head of BIH Biomedical Innovation Academy (BIA)
  • Head of BIH Application and Reporting Portal

Dr. Iwan Meij is joint head of BIA. He holds a PhD in medical sciences and molecular biology and has a long-time experience in the development of career support measures for early career biomedical researchers, including career stage specific, tailormade learning offers. Originally from the Max Delbrück Center, where among other things, he coordinated the Helmholtz PhD-Research School TransCard, he transferred to BIH in 2013 to coordinate its educational branch, which later became BIH´s Biomedical Innovation Academy. 

 

Gabriela Böhme

Coordinator BIA - national Translational Tandem Program for Gene- and Cell-based Therapies (nTTP-GCT)

 

Contact
Phone: +49 (0) 30 450 543 351 
E-Mail: nttp-gct@bih-charite.de

 

Gabriela Böhme is a certified biologist with many years of experience in biomedical research and development as well as in study and project management (industry and academia).

As coordinator of the nTTP-GCT, she is the first point of contact for fellows and interested parties.